Journal article
Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis
BG Schimmelmann, P Conus, S Cotton, S Kupferschmid, PD McGorry, M Lambert
European Psychiatry | Published : 2012
Abstract
Background: Previous studies on the impact of cannabis use disorders (CU) on outcome in psychosis were predominantly based on non representative samples, often have not controlled for confounders and rarely focused on adolescent patients. Thus, the aims of the present study were to assess: (i) prevalence of CU; (ii) baseline and pretreatment differences between CU and those without CU (NCU); (iii) the impact of baseline and course of CU on 18-month outcomes in a representative cohort of adolescents with early onset first episode psychosis (EOP). Methods: The sample comprised 99 adolescents (age 14 to 18) with EOP (onset age 14 to 17), admitted to the Early Psychosis Prevention and Interventi..
View full abstractGrants
Funding Acknowledgements
[ "Eli Lilly Australia funded the assessment of files on a subgroup of this cohort treated with olanzapine and risperidone.", "The acquisition of data was in part supported by the Colonial Foundation, National Health and Medical Research Council and Eli Lilly Australia. Drs. Schimmelmann, Conus, McGorry, and Lambert have received research funding from and/or served as paid speaker for Eli Lilly.", "Dr. Philippe Conus is supported by the Leenaards Foundation, Switzerland. Dr Sue Cotton is supported by the Ronald Phillip Griffith Fellowship, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne." ]